These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20924102)

  • 1. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
    Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.
    Powell DJ; Attia P; Ghetie V; Schindler J; Vitetta ES; Rosenberg SA
    J Immunother; 2008; 31(2):189-98. PubMed ID: 18481388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic depletion of CCR8
    Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity.
    Yan X; Zhang X; Wang Y; Li X; Wang S; Zhao B; Li Y; Ju Y; Chen L; Liu W; Meng S
    Cancer Immunol Immunother; 2011 Dec; 60(12):1763-74. PubMed ID: 21789592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulation.
    Bhanumathy KK; Zhang B; Ahmed KA; Qureshi M; Xie Y; Tao M; Tan X; Xiang J
    Int J Mol Sci; 2014 Mar; 15(4):5508-21. PubMed ID: 24690994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
    Manukian G; Kivolowitz C; DeAngelis T; Shastri AA; Savage JE; Camphausen K; Rodeck U; Zarif JC; Simone NL
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1341-1349. PubMed ID: 33647370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic DNA vaccine targeting Foxp3
    Namdar A; Mirzaei R; Memarnejadian A; Boghosian R; Samadi M; Mirzaei HR; Farajifard H; Zavar M; Azadmanesh K; Elahi S; Noorbakhsh F; Rezaei A; Hadjati J
    Cancer Immunol Immunother; 2018 Mar; 67(3):367-379. PubMed ID: 29124314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient Treg depletion enhances therapeutic anti-cancer vaccination.
    Fisher SA; Aston WJ; Chee J; Khong A; Cleaver AL; Solin JN; Ma S; Lesterhuis WJ; Dick I; Holt RA; Creaney J; Boon L; Robinson B; Lake RA
    Immun Inflamm Dis; 2017 Mar; 5(1):16-28. PubMed ID: 28250921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
    Ganesan AP; Johansson M; Ruffell B; Yagui-Beltrán A; Lau J; Jablons DM; Coussens LM
    J Immunol; 2013 Aug; 191(4):2009-17. PubMed ID: 23851682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients.
    Ridolfi L; Petrini M; Granato AM; Gentilcore G; Simeone E; Ascierto PA; Pancisi E; Ancarani V; Fiammenghi L; Guidoboni M; de Rosa F; Valmorri L; Scarpi E; Nicoletti SV; Baravelli S; Riccobon A; Ridolfi R
    J Transl Med; 2013 May; 11():135. PubMed ID: 23725550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
    Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
    Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC
    Akeus P; Szeponik L; Ahlmanner F; Sundström P; Alsén S; Gustavsson B; Sparwasser T; Raghavan S; Quiding-Järbrink M
    Cancer Immunol Immunother; 2018 Jul; 67(7):1067-1077. PubMed ID: 29671006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells.
    Galvin KC; Dyck L; Marshall NA; Stefanska AM; Walsh KP; Moran B; Higgins SC; Dungan LS; Mills KH
    Cancer Immunol Immunother; 2013 Jul; 62(7):1273-82. PubMed ID: 23657628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.
    Kurebayashi Y; Olkowski CP; Lane KC; Vasalatiy OV; Xu BC; Okada R; Furusawa A; Choyke PL; Kobayashi H; Sato N
    Cancer Res; 2021 Jun; 81(11):3092-3104. PubMed ID: 33574087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine.
    Liu JY; Wu Y; Zhang XS; Yang JL; Li HL; Mao YQ; Wang Y; Cheng X; Li YQ; Xia JC; Masucci M; Zeng YX
    Cancer Immunol Immunother; 2007 Oct; 56(10):1597-604. PubMed ID: 17440723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
    Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
    Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
    [No Abstract]   [Full Text] [Related]  

  • 17. Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
    Imai H; Saio M; Nonaka K; Suwa T; Umemura N; Ouyang GF; Nakagawa J; Tomita H; Osada S; Sugiyama Y; Adachi Y; Takami T
    Cancer Sci; 2007 Mar; 98(3):416-23. PubMed ID: 17270031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model.
    Foureau DM; McKillop IH; Jones CP; Amin A; White RL; Salo JC
    Cancer Immunol Immunother; 2011 Sep; 60(9):1347-56. PubMed ID: 21638127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T Cells.
    Piovesan D; de Groot AE; Cho S; Anderson AE; Ray RD; Patnaik A; Foster PG; Mitchell CG; Lopez Espinoza AY; Zhu WS; Stagnaro CE; Singh H; Zhao X; Seitz L; Walker NP; Walters MJ; Sivick KE
    Cancer Res; 2024 Jun; 84(12):1978-1995. PubMed ID: 38635895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin Corrects T Regulatory Cell Depletion and Improves Embryo Implantation and Live Birth Rates in a Murine Model.
    Royster GD; Harris JC; Nelson A; Castro Y; Weitzel RP; Tisdale J; Heitmann RJ; DeCherney AH; Wolff EF
    Reprod Sci; 2019 Dec; 26(12):1545-1556. PubMed ID: 30782087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.